Search

Displaying results 61 - 70 of 78 in total
  1. Indication

    Locally advanced Urothelial Carcinoma

    go.drugbank.com/conditions/DBCOND0089492
    Drugs: Avelumab · Durvalumab · Nivolumab · Pembrolizumab
  2. Indication

    Adenocarcinoma, Renal

    go.drugbank.com/conditions/DBCOND0126095
    Drugs: Belzutifan · Interferon alfa · Pembrolizumab · Sunitinib · Tivozanib
  3. Indication

    Recurrent Cervical Cancer

    go.drugbank.com/conditions/DBCOND0028795
    Drugs: Bevacizumab · Cemiplimab · Pembrolizumab · Tisotumab vedotin · Vinorelbine
  4. Indication

    Muscle-invasive Bladder Cancer

    go.drugbank.com/conditions/DBCOND0042339
    Drugs: Atezolizumab · Durvalumab · Enfortumab vedotin · Pembrolizumab
  5. Indication

    Platinum-resistant Epithelial Ovarian Cancer

    go.drugbank.com/conditions/DBCOND0087629
    Drugs: Capecitabine · Mirvetuximab soravtansine · Pembrolizumab · Relacorilant
  6. Indication

    Locally Advanced or Metastatic Urothelial Carcinoma (UC)

    go.drugbank.com/conditions/DBCOND0123651
    Drugs: Enfortumab vedotin · Erdafitinib · Pembrolizumab · Sacituzumab govitecan
  7. Indication

    Resectable Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0068626
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  8. Indication

    Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    go.drugbank.com/conditions/DBCOND0144294
    Drugs: Cetuximab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  9. Indication

    Metastatic Renal Cell Carcinoma ( mRCC)

    go.drugbank.com/conditions/DBCOND0123126
    Drugs: Aldesleukin · Bevacizumab · Medroxyprogesterone acetate · Nivolumab · Pembrolizumab
  10. Indication

    Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0034130
    Drugs: Etoposide · Irinotecan · Mitomycin · Paclitaxel · Pembrolizumab · Vinblastine